This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 results revenue up sharply but losses widen qualified auditor opinion
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Q2 FY27 revenue surged to Rs 142.90 lakhs from Rs 0.01 lakh a year ago. But loss after tax was Rs 6.02 lakhs in Q2 versus Rs 7.42 lakh loss a year ago. Half year loss widened to Rs 77.81 lakhs from Rs 6.89 lakhs. Reserves turned negative at Rs 361.44 lakhs. Operating cash outflow of Rs 182.72 lakhs. Auditor VSSB and Associates gave a qualified review, flagging missing balance confirmations for receivables and payables.
Revenue surge positive but widening losses, negative reserves, weak cash flow and qualified auditor review may weigh on investor confidence.
The company's XBRL figures for this quarter look filed in the wrong unit: revenue reads ₹1.43 Cr against ₹0.00 Cr a year ago, about 14,290× larger. A move that size is almost always a wrong unit, not a business, so nothing is computed from these figures and no number-based tags are set; the read above is the AI's, from the document.